Ligand validation:4BC0

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4BC0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BC0_NAG_D_701	20%	50%	0.263	0.865	0.55	1.36	-	2	0	0	100%	0.9333
4BC0_NAG_A_701	12%	61%	0.365	0.896	0.51	0.97	-	2	0	0	100%	0.9333
4BC0_NAG_B_701	11%	34%	0.237	0.753	0.47	2.21	-	6	1	0	100%	0.9333
4BC0_NAG_B_702	3%	43%	0.408	0.736	0.61	1.61	-	2	0	0	100%	0.9333
4BC0_NAG_D_703	2%	57%	0.42	0.729	0.51	1.11	-	1	0	0	100%	0.9333
4BC0_NAG_D_702	2%	28%	0.371	0.656	0.99	2.02	1	6	1	1	100%	0.9333
4BC0_NAG_C_701	2%	56%	0.527	0.783	0.41	1.27	-	2	0	0	93%	0.756
2WHP_NAG_A_601	47%	54%	0.171	0.909	0.43	1.31	-	2	0	0	100%	0.6533
5EHQ_NAG_A_1503	33%	68%	0.19	0.871	0.41	0.79	-	1	0	0	100%	0.9333
5FKJ_NAG_D_560	26%	70%	0.18	0.821	0.53	0.62	-	1	0	0	100%	0.84
4A16_NAG_B_1546	26%	17%	0.167	0.816	1.13	2.6	1	7	5	0	93%	0.9333
4BC1_NAG_B_701	22%	46%	0.179	0.79	0.47	1.62	-	3	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.